Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: A deep learning approach to antibiotic discovery

PROVIDER: PRJNA598708 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10820656_1.fastq.gz	Fastqsanger.gz
	SRR10820656_2.fastq.gz	Fastqsanger.gz
	SRR10820657_1.fastq.gz	Fastqsanger.gz
	SRR10820657_2.fastq.gz	Fastqsanger.gz
	SRR10820658_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 68

Similar Datasets

Deep learning-guided discovery of a narrow-spectrum antibiotic against Acinetobacter baumannii

Project description:Deep learning-guided discovery of a narrow-spectrum antibiotic against Acinetobacter baumannii

| PRJNA884833 | ENA

Thermal proteome profiling of stationary-phase E. coli treated with semapimod

Project description:There is a need to discover and develop non-toxic antibiotics that are effective against metabolically dormant bacteria, which underlie chronic infections and promote antibiotic resistance. Traditional antibiotic discovery has historically favored compounds effective against actively metabolizing cells, a property that is not predictive of efficacy in metabolically inactive contexts. Here, we combine a stationary-phase screening method with deep learning-powered virtual screens and toxicity filtering to discover compounds with lethality against metabolically dormant bacteria and favorable toxicity profiles. The most potent and structurally novel compound without any obvious mechanistic liability was semapimod, an anti-inflammatory drug effective against stationary-phase E. coli and A. baumannii. Integrating microbiological assays, biochemical measurements, and single-cell microscopy, we show that semapimod selectively disrupts and permeabilizes the bacterial outer membrane by binding lipopolysaccharide. This work illustrates the value of harnessing non-traditional screening methods and deep learning models to identify non-toxic antibacterial compounds that are effective in infection-relevant contexts.

2023-08-21 | PXD044230 | Pride

A Deep Learning Approach For Programmable RNA Switches

Project description:A Deep Learning Approach For Programmable RNA Switches

| PRJNA627694 | ENA

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes

Project description:Drug-induced cardiotoxicity and hepatotoxicity are major causes of drug attrition. To decrease late-stage drug attrition, pharmaceutical and biotechnology industries need to establish biologically relevant models that use phenotypic screening to detect drug-induced toxicity in vitro. In this study, we sought to rapidly detect patterns of cardiotoxicity using high-content image analysis with deep learning and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). We screened a library of 1280 bioactive compounds and identified those with potential cardiotoxic liabilities in iPSC-CMs using a single-parameter score based on deep learning. Compounds demonstrating cardiotoxicity in iPSC-CMs included DNA intercalators, ion channel blockers, epidermal growth factor receptor, cyclin-dependent kinase, and multi-kinase inhibitors. We also screened a diverse library of molecules with unknown targets and identified chemical frameworks that show cardiotoxic signal in iPSC-CMs. By using this screening approach during target discovery and lead optimization, we can de-risk early-stage drug discovery. We show that the broad applicability of combining deep learning with iPSC technology is an effective way to interrogate cellular phenotypes and identify drugs that may protect against diseased phenotypes and deleterious mutations.

2021-07-07 | GSE172181 | GEO

A Deep Learning based Efficacy Prediction System for Drug Discovery

Project description:A Deep Learning based Efficacy Prediction System for Drug Discovery

| PRJNA693487 | ENA

Project description:Discovery of a structural class of antibiotics with explainable deep learning

| PRJNA1026995 | ENA

A Deep Learning based Efficacy Prediction System for Drug Discovery [Perillen]

Project description:A Deep Learning based Efficacy Prediction System for Drug Discovery [Perillen]

| PRJNA693496 | ENA

A Deep Learning based Efficacy Prediction System for Drug Discovery [Trametinib]

Project description:A Deep Learning based Efficacy Prediction System for Drug Discovery [Trametinib]

| PRJNA693497 | ENA